{"id":"W4410812803","doi":"10.1200/jco.2025.43.16_suppl.tps7568","title":"MagnetisMM-32: A phase 3 randomized study of elranatamab vs EPd, PVd, or Kd in patients with relapsed or refractory multiple myeloma (RRMM) and prior anti-CD38–directed therapy.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Pfizer","keywords":"Medicine; Refractory (planetary science); Multiple myeloma; Lenalidomide; Oncology; Internal medicine; Metallurgy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003223497,0.002237205,0.002019905,0.0005604287,0.0006331553,0.001190308,0.001128895,0.001871421,0.009785257],"category_scores_gemma":[0.001805829,0.0008417223,0.002091937,0.0004467736,0.001118861,0.001140913,0.0005937803,0.00449162,0.001598807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001238639,"about_ca_system_score_gemma":0.002372044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001278809,"about_ca_topic_score_gemma":0.004382139,"domain_scores_codex":[0.9992779,0.0004386875,0.00002637665,0.00008575394,0.00004954356,0.0001217867],"domain_scores_gemma":[0.9988715,0.0002181024,0.0002492632,0.00006144496,0.00005107831,0.0005485615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9368708,0.02559895,0.001166917,0.0005118481,0.000768583,0.00009319196,0.0001129264,0.000753529,0.007919689,0.0002633205,0.002987295,0.02295293],"study_design_scores_gemma":[0.8986368,0.09684912,0.001797162,0.00002684733,0.0002444213,0.00005542108,0.00001920715,0.000500018,0.0004531688,0.0002300749,0.001168903,0.00001889805],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9751925,0.003246276,0.0009037287,0.00188426,0.0005699957,0.01220579,0.002514949,0.0002239786,0.003258525],"genre_scores_gemma":[0.9718809,0.001926565,0.003150244,0.002912065,0.0004774778,0.01274147,0.002069701,0.00006170301,0.004779888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009785257,"threshold_uncertainty_score":0.03273499,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0720768217424995,"score_gpt":0.4572068126716047,"score_spread":0.3851299909291052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}